| 
NINDS - AIREN criteria for the diagnosis
of vascular dementia |
I. The criteria for the clinical diagnosis of
probable vascular dementia include all of
the following:
-
Dementia defined by cognitive decline
from a previously higher level of functioning and manifested
by impairment of memory and of two or more cognitive domains
(orientation, attention, language, visuospatial functions,
executive functions, motor control, and praxis), preferable
established by clinical examination and documented by
neuropsychological testing; deficits should be severe
enough to interfere with activities of daily living not
due to physical effects of stroke alone.
Exclusion criteria: cases with disturbance of
consciousness, delirium, psychosis, severe aphasia, or
major sensorimotor impairment precluding neuropsychological
testing. Also excluded are systemic disorders or other
brain diseases (such as AD) that in and of themselves
could account for deficits in memory and cognition.
-
Cerebrovascular disease, defined
by the presence of focal signs on neurologic examination,
such as hemiparesis, lower facial weakness, Babinski sign,
sensory deficit, hemianopia, and dysarthria consistent
with stroke (with or without history of stroke), and evidence
of nof relevant CVD by brain imaging (CT or MRI) including
multiple large vessel infarcts or a single
strategically placed infarct (angular gyrus, thalamus,
basal forebrain, or PCA or ACA territories), as well as
multiple basal ganglia and white matter lacunes,
or extensive periventricular white matter lesions,
or combinations thereof.
- A relationship between the above two disorders,
manifested or inferred by the presence of one or more of
the following: (a) onset of dementia within 3 months following
a recognized stroke; (b) abrupt deterioration in cognitive
functions; or fluctuating, stepwise progression of cognitive
deficits.
II. Clinical features consistent with the diagnosis
of probable vascular dementia include the following:
(a) Early presence of gait disturbance (small-step
gait or marche a petits pas, or magnetic, apraxic-ataxic
or parkinsonian gait); (b) history of unsteadiness and frequent,
unprovoked falls; (c) early urinary frequency, urgency,
and other urinary symptoms not explained by urologic disease;
(d) pseudobulbar palsy; and (e) personality and mood changes,
abulia, depression, emotional incontinence, or other subcortical
deficits including psychomotor retardation and abnormal
executive function.
III. Features that make the diagnosis of vascular
dementia uncertain or unlikely include (a) early onset of
of memory deficit and progressive worsening of memory deficit
and progressive worsening of memory and other cognitive functions
such as language (transcortical sensory aphasia), motor skills
(apraxia), and perception (agnosia), in the absence of corresponding
focal lesions on brain imaging; (b) absence of focal neurological
signs, other than cognitive disturbance; and (c) absence of
cerebrovascular lesions on brain CT or MRI.
IV. Clinical diagnosis of possible
vascular dementia may be made in the presence of dementia
(section I-1) with focal neurologic signs in patients in whom
brain imaging studies to confirm definite CVD are missing;
or in the absence of clear temporal relationship between dementia
and stroke; or in patients with subtle onset and variable
course (plateau or improvement) of cognitive deficits and
evidence of relevant CVD.
V. Criteria for diagnosis of definite
vascular dementia are (a) clinical criteria for probable
vascular dementia; (b) histopathologic evidence of CVD obtained
from biopsy or autopsy; (c) absence of neurofibrillary tangles
and neuritic plaques exceeding those expected for age; and
(d) absence of other clinical or pathological disorder capable
of producing dementia.
VI. Classification of vascular dementia for
research purposes may be made on the basis of clinical, radiologic,
and neuropathologic features, for subcategories or defined
conditions such as cortical vascular dementia, subcortical
vascular dementia, BD, and thalamic dementia.
The term "AD with CVD" should be reserved
to classify patients fulfilling the clinical criteria for
possible AD and who also present clinical or brain imaging
evidence of relevant CVD. Traditionally, these patients have
been included with VaD in epidemiologic studies. The term
"mixed dementia," used hitherto, should be avoided.
Reference
Roman GC, Tatemichi TK, Erkinjuntti T, Cummings
JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A,
Hofman A, et al. Vascular dementia: diagnostic criteria for
research studies. Report of the NINDS-AIREN International
Workshop.
Neurology
1993 Feb;43(2):250-60.
|